| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.067 | 0.4 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.4 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |